Clarithromycin Modified Release Observational Study for Evaluation of Treatment, Tolerability & Recovery Time in Saudi & Egyptian Clinical Settings (CLOSER)

NCT01075204 · clinicaltrials.gov ↗

COMPLETED

Status

335

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Tract Infection

Interventions

DRUG: clarithromycin modified release 500 mg

Sponsor

Abbott

Collaborators

[object Object]